Can loose joints worsen lipedema pain? researchers investigate

NCT ID NCT07808242

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This observational study asks whether women with lipedema, a condition that causes abnormal fat buildup in the legs, are more likely to have joint hypermobility, or unusually loose joints, compared to healthy women of similar age and weight. Researchers will measure joint looseness, pain, posture, and quality of life in 65 women with lipedema and 65 healthy volunteers. The goal is to see if hypermobility relates to more severe symptoms or a lower quality of life in lipedema.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study finds a clear link, it could point toward better ways to spot and manage joint problems in women with lipedema.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply beyond the Turkish population studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

130 people

The number who actually took part.

Started

Aug 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Lipedema Group: Female patients, aged between 18 and 65 years, who were clinically diagnosed with lipedema based on detailed physical examination and clinical assessments. The participants were evaluated and recruited at the Dokuz Eylul University Faculty of Medicine, Department of Physical Medicine and Rehabilitation Outpatient Clinic. Control Group: Healthy female volunteers, aged between 18 and 65 years, who were strictly matched to the lipedema group in terms of age and Body Mass Index (BMI).

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For Lipedema Group: Aged between 18-65 years. Diagnosed with lipedema. Willing to participate in the study. Having a socio-cultural level suitable for study participation. * For Control Group: Aged between 18-65 years. Willing to participate in the study. Having a socio-cultural level suitable for study participation. Exclusion Criteria: * For Lipedema Group: Uncontrolled thyroid dysfunction. Chronic venous insufficiency and/or lymphedema (Stage 4 lipedema). Acute or chronic renal failure. Heart failure. Active cancer or ongoing cancer treatment. Presence of neurological disease. Presence of rheumatological disease. History of liposuction or major surgery for lipedema within the last 6 months. Visual or hearing impairment severe enough to affect study compliance. Illiteracy or cognitive impairment preventing the ability to give written informed consent. * For Control Group: Previous diagnosis of lipedema, lymphedema, chronic venous insufficiency. History of rheumatologic, neurologic, endocrinologic, or cardiovascular diseases. Uncontrolled thyroid dysfunction. History of acute or chronic renal failure, heart failure, active cancer, or ongoing cancer treatment. Orthopedic problems affecting lower extremities, trauma, or history of liposuction/major surgery within the last 6 months. Regular use of medications that may affect pain threshold (e.g., systemic corticosteroids, antidepressants, anticonvulsants, etc.). Physical barriers affecting pain assessment (algometry, VAS) or postural observation (e.g., severe vision/hearing loss, local skin lesions, amputation, etc.). Cognitive impairment or lack of literacy preventing written informed consent. Psychiatric illness preventing compliance with the study process or communication problems affecting cooperation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypermobility, joint are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dokuz Eylul University Faculty of Medicine Hospital

    Izmir, 35330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.